MgIClinicalStudies.com

Title

Irofulven: Prostate Cancer

Description

Phase II clinical trial for hormone-refractory disease by the MGI Pharma company.

Contact

MGI PHARMA, Inc.
Bloomington MN
US 55437
5775

Additional Information

Related Domains



Retrieved from "http://aboutus.com/index.php?title=MgIClinicalStudies.com&oldid=14380421"